Tidswell, M; Tillis, W; Larosa, SP; Lynn, M; Wittek, AE; Kao, R; Wheeler, J; Gogate, J; et al. (2010). "Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis". Critical Care Medicine38 (1): 72–83. PMID19661804. doi:10.1097/CCM.0b013e3181b07b78.
Beutler, B.; Poltorak, A. (2001-04-01). "The sole gateway to endotoxin response: how LPS was identified as Tlr4, and its role in innate immunity". Drug Metabolism and Disposition29 (4 Pt 2): 474–478. ISSN0090-9556. PMID11259335.
Tidswell, M; Tillis, W; Larosa, SP; Lynn, M; Wittek, AE; Kao, R; Wheeler, J; Gogate, J; et al. (2010). "Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis". Critical Care Medicine38 (1): 72–83. PMID19661804. doi:10.1097/CCM.0b013e3181b07b78.
Beutler, B.; Poltorak, A. (2001-04-01). "The sole gateway to endotoxin response: how LPS was identified as Tlr4, and its role in innate immunity". Drug Metabolism and Disposition29 (4 Pt 2): 474–478. ISSN0090-9556. PMID11259335.